Transcription of LOXALATE 1. Product Name - Medsafe Home Page
{{id}} {{{paragraph}}}
Example: biology
LOXALATE 1. Product Name - Medsafe Home Page
Page 1 of 21 NEW ZEALAND DATA SHEETLOXALATE1. Product NameLOXALATE, 5 mg, 10 mg, 20 mg, film-coated Qualitative and Quantitative CompositionEach tablet contains 5 mg, 10 mg or 20 mgof coating on each tablet, OpadryWhite, contains the full list of excipients, see section Pharmaceutical FormLoxalate Tablets 5mg: normal convex white film coated tablet debossed EC over 5 on one side and G on the other. LOXALATE Tablets 10 mg: mm x mm oblong normal convex white film coated tablet debossed EC|10 on one side and G on the other. LOXALATE Tablets 20 mg: x 7 mm oblong normal convex white film coated tablet debossed EC|20 on one side and G on the not halveLoxalate 5mg Clinical Therapeutic indicationsAdults - Treatment of major and method of administrationDo not halve LOXALATE 5mg recommended dose is 10 mg once daily. Depending on individual patient response, the dose may be increased to a maximum of 20mg 2-4 weeks are necessary for antidepressant response, although the onset of therapeutic effect may be seen earlier.
Page 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: